Risk of Heart Failure in Patients With Recent-Onset Type 2 Diabetes: Population-Based Cohort Study

Journal of Cardiac Failure

Volumn 15, Issue 2, 2009, Pages 152-157

  Leung, Alexander A ^a   Eurich, Dean T ^b   Lamb, Darcy A ^c   Majumdar, Sumit R ^a   Johnson, Jeffrey A ^b   Blackburn, David F ^c   McAlister, Finlay A ^a  

^a Faculty of Medicine and Dentistry   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Heart failure incidence; type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; COHORT STUDIES; CONFIDENCE INTERVALS; DATABASES AS TOPIC; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; MIDDLE AGED; RISK; RISK FACTORS; SEX FACTORS; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 60949108412     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.10.004     Document Type: Article

References (32)

1. ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
2. Korum H., and Gilbert R.E. Demographics and concomitant disorders in heart failure. Lancet 362 (2003) 147-158
3. Bertini G.A., Handley W.A.G., Massing M.W., Bonds D.E., Burke G.L., and Guff Jr. D.C. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 27 (2004) 699-703
4. Nichols G.A., Hillier T.A., Erbe J.R., and Brown J.B. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 24 (2001) 1614-1619
5. McAlister F.A., and Eurich D.T. Heart failure and diabetes. In: Johnson J.A. (Ed). Alberta diabetes atlas 2007 (2007), Institute of Health Economics, Alberta, Canada 57-62
6. Kennel W.B., Shorthand M., and Cantelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34 (1974) 29-34
7. Hush K.K.K. Thiazolidinediones in heart failure: slippery when wet. J Card Failure 14 (2008) 453-455
8. Eurich D.T., Majumdar S.R., McAlister F.A., Suzuki R.T., and Johnson J.A. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 28 (2005) 2345-2351
9. Eurich D.T., Majumdar S.R., Suzuki R.T., and Johnson J.A. Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetes. Diabetes Care 27 (2004) 1330-1334
10. Downey W., Sting M.R., Beck P., Ossei W., and Nichols J. Health services databases in Saskatchewan. In: Strom B.B.L. (Ed). Pharmacoepidemiology. 4th ed. (2005), John Wiley & Sons, Ltd, Chi Chester, UK 295-310
11. Ray W.A. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 158 (2003) 915-920
12. Quant H., Parsons G.A., and Gail W.A. Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 40 (2002) 675-685
13. Guff Jr. D.C., Pandy D.K., Cham F.A., Otis C., and Nichamin M.S. Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project. Arch Intern Med 160 (2000) 197-202
14. Lee D.S., Donovan L., Austin P.C., Gong Y., Leu P.P., Rouleau J.L., et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 43 (2005) 480-485
15. Statistics Canada. Canada's national statistical agency. Population and dwelling counts, for Canada, provinces and territories, 1991 and 1996 censuses. Available from http://www.statcan.ca/english/census96/table1e.pdf. Accessed 25 September 2008.
16. Nichols G.A., Gullion C.M., Koro C.E., Ephors S.A., and Brown J.B. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27 (2004) 1879-1884
17. Levy D., Larson M.G., Vasan R.S., Kennel W.B., and Ho K.K.K. The progression from hypertension to congestive heart failure. JAMA 275 (1996) 1557-1562
18. Bertini G.A., Tsai A., and Casper E.E.K. Bran cati FL. Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 26 (2003) 2791-2795
19. Aronow W.S., and Ahn C. Incidence of heart failure in 2,737 older persons with and without diabetes mellitus. Chest 115 (1999) 867-868
20. De Groove P., Lambkin N., Bouquet F., Lichen D., Macfadyena E., Van Belle E., et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Euro Heart J 25 (2004) 656-662
21. Marcia A.M., Heinekens C.H., Lamas G.A., Jiménez-Navarro M., Rouleau J.L., Flaker G.C., et al. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch Intern Med 164 (2004) 2273-2279
22. Kamalesh M., Subramanian U., Sawada S., Eckert G., Temkit M., and Tierney W. Decreased survival in diabetic patients with heart failure due to systolic dysfunction. Eur J Heart Fail 8 (2006) 404-408
23. Varela-Roman A., Grigorian Shamagian L., Barge Caballero E., Mazon Ramos P., Rigueiro Veloso P., and Gonzalez-Juanatey J.R. Influence of diabetes on the survival of patients hospitalized with heart failure: a 12-year study. Eur J Heart Fail 7 (2005) 859-864
24. Investigators ONTARGET/TRANSCEND. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation 115 (2007) 1371-1375
25. Bell D.S. Heart failure in the diabetic patient. Cardiol Clin 25 (2007) 523-538
26. McAlister F.A., Eurich D.T., Majumdar S.R., and Johnson J.A. The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy. Eur J Heart Fail 10 (2008) 703-708
27. Lago R.M., Singh P.P., and Nesto R.W. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet 370 (2007) 1129-1136
28. Boudina S., and Abel E.D. Diabetic cardiomyopathy revisited. Circulation 115 (2007) 3213-3223
29. Spoelstra J.A., Stolk R.P., Klungel O.H., Erkens J.A., Rutten G.E., Leufkens H.G., et al. Initiation of glucose-lowering therapy in type 2 diabetes mellitus patients in general practice. Diabetes Med 21 (2004) 896-900
30. Hippisley-Cox J., and Pringle M. Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional survey. Lancet 364 (2004) 423-428
31. Nesto R.W., Le Winter M., Bell D., Porte D., Bonow R.O., Semenkovich C.F., et al. Thiazolidinedione use, fluid retention, and congestive heart failure. A consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care 27 (2004) 256-263
32. Padwal R. Thiazolidinediones increased risk for heart failure, myocardial infarction, and death in older patients with type 2 diabetes. ACP J Club 148 (2008) 13